Skip to main content
. 2018 Mar 23;2018(3):CD010840. doi: 10.1002/14651858.CD010840.pub2
CBT versus unspecific control conditions
Analysis Name Control MD 95% CI % change
Analysis 1.1
ADHD symptoms
(observer)
1.1.1 Solanto 2010 73.19 −6.25 −11.04 −1.46 −9% (95% CI −15 to −2)
1.1.2a Hepark 2015 28.00 −6.5 −9.77 −3.23 −23% (95% CI −35 to −12)
1.1.2b Stevenson 2002 112.9 −39.2 −52.76 −25.64 −35% (95% CI −47 to −23)
Analysis 1.2
ADHD symptoms
(self‐reported)
1.2.1a Hirvikoski 2011 27.28 −2.81 −8.02 2.4 −10% (95% CI −29 to 9)
1.2.1b Solanto 2010 76.8 −1.00 −6.15 4.15 −1% (95% CI −8 to 5)
1.2.2a Gu 2017 71.77 −11.06 −15.75 −6.37 −15% (95% CI −22 to −9)
1.2.2b Hepark 2015 28.8 −5.8 −8.86 −2.74 −20% (95% CI −31 to −10)
1.2.2c Pettersson 2017 29.72 −2.38 −8.11 3.35 −8% (95% CI −27 to 11)
1.2.2d Schoenberg 2014 31.3 −8.3 −12.53 −4.07 −27% (95% CI −40 to −13)
1.2.2e Virta 2010 −4.6 −8.7 −17.47 0.07 189% (95% CI −2 to 380)
Analysis 1.3
Inattention
(clinician)
1.3.1 Solanto 2010 16.18 −2.47 −4.43 −0.51 −15% (95% CI −27 to −3)
1.3.2 Hepark 2015 16.5 −4.1 −6.00 −2.2 −25% (95% CI −36 to −13)
Analysis 1.4
Inattention (self‐reported)
1.4.1a Gu 2017 64.23 −12.59 −17.53 −7.65 −20% (95% CI −27 to −12)
1.4.1b Hepark 2015 16.1 −3.3 −5.02 −1.58 −20% (95% CI −31 to −10)
1.4.2c Moëll 2015 27.93 −5.01 −7.16 −2.86 −18% (95% CI −26 to −10)
1.4.2d Schoenberg 2014 17.4 −5.2 −7.47 −2.93 −30% (95% CI −43 to −17)
Analysis 1.5
Hyperactivity‐impulsivity (clinician)
1.5.1 Hepark 2015 11.5 −2.5 −4.63 −0.37 −22% (95% CI −40 to −3)
Analysis 1.6
Hyperactivity‐impulsivity
(self‐reported)
1.6.1a Gu 2017 71.15 −10.29 −14.91 −5.67 −14% (95% CI −21 to −8)
1.6.1b Hepark 2015 12.6 −2.3 −4.28 0.32 −18% (95% CI −34 to 3)
1.6.1c Moëll 2015 20.85 −1.31 −4.81 2.19 −6% (95% CI −23 to 11)
1.6.1d Schoenberg 2014 14.00 −3.2 −6.05 −0.35 −23% (95% CI −43 to −3)
Analysis 1.7
Depression (self‐reported)
1.7.1 Solanto 2010 9.08 0.58 −2.8 3.96 6% (95% CI −31 to 44)
1.7.2a Gu 2017 9.42 −2.35 −4.01 −0.69 −25% (95% CI −43 to −7)
1.7.2b Hepark 2015 11.8 −2.7 −6.51 1.11 −23% (95% CI −55 to 9)
1.7.2c Moëll 2015 7.7 −1.08 −3.48 1.32 −14% (95% CI −45 to 17)
1.7.2d Pettersson 2017 15.11 −1.92 −8.63 4.79 −13% (95% CI −57 to 32)
1.7.2e Virta 2010 −1.5 −3.1 −10.22 4.02 207% (95% CI −268 to 681)
Analysis 1.8 Anxiety (clinician) 1.8.1 Solanto 2010 8.88 −0.81 −3.21 1.59 −9% (95% CI −36 to 18)
Analysis 1.9
Anxiety (self‐reported)
1.9.1a Gu 2017 15.08 −5.58 −8.97 −2.19 −37% (95% CI −59 to −15)
1.9.1b Hepark 2015 90.8 −12.3 −22.56 −2.04 −14% (95% CI −25 to −2)
1.9.1c Moëll 2015 8.81 −0.85 −2.67 0.97 −10% (95% CI −30 to 11)
1.9.1d Pettersson 2017 15.22 −1.55 −8.04 4.94 −10% (95% CI −53 to 32)
Analysis 1.10 State anger (self‐reported) 1.10.1 Stevenson 2002 14.00 −3.3 −5.62 −0.98 −24% (95% CI −40 to −7)
Analysis 1.11 Trait anger (self‐reported) 1.11.1 Stevenson 2002 24.3 −3.8 −7.63 0.03 −16% (95% CI −31 to 0)
Analysis 1.12
Self‐steem (self‐reported)
1.12.1 Solanto 2010 −1.3 0.00 −1.85 1.85 0% (95% CI −142 to 142)
1.12.2 Stevenson 2002 97.4 12.4 4.55 20.25 13% (95% CI 5 to 21)
Analysis 1.13
Qualfeity of life (self‐reported)
1.13.1a Pettersson 2017 41.91 4.99 −6.23 16.21 12% (95% CI −15 to 39)
1.13.1b Virta 2010 59.2 1.7 −14.7 18.1 3% (95% CI −25 to 31)
CBT plus pharmacotherapy versus pharmacotherapy alone
Analysis Name Control MD 95% CI % change
Analysis 2.1
ADHD symptoms (clinician)
2.1a Emilsson 2011 35.94 −6.06 −10.01 −2.11 −17% (95% CI −28 to −6)
2.1b Safren 2005 20.8 −5.61 −12.11 0.89 −27% (95% CI −58 to 4)
Analysis 2.2
ADHD symptoms (self‐reported)
2.2a Emilsson 2011 23.47 −6.25 −11.72 −0.78 −27% (95% CI −50 to −3)
2.2b Safren 2005 23.87 −9.12 −15.69 −2.55 −38% (95% CI −66 to −11)
Analysis 2.3 Inattention (self‐reported) 2.3 Emilsson 2011 14.71 −4.54 −7.75 −1.33 −31% (95% CI −53 to −9)
Analysis 2.4
Hyperactivity‐impulsivity (self‐reported)
2.4 Emilsson 2011 8.76 −1.7 −5.29 1.89 −19% (95% CI −60 to 22)
Analysis 2.5
Clinical Global Impression (clinician)
2.5a Emilsson 2011 3.88 −0.7 −1.31 −0.09 −18% (95% CI −34 to −2)
2.5b Safren 2005 4.13 −0.82 −1.51 −0.13 −20% (95% CI −37 to −3)
Analysis 2.6 Depression (clinician) 2.6 Safren 2005 10.00 −5.56 −9.71 −1.41 −56% (95% CI −97 to −14)
Analysis 2.7
Depression (self‐reported)
2.7a Emilsson 2011 15.41 −8.19 −13.76 −2.62 −53% (95% CI −89 to −17)
2.7b Safren 2005 12.4 −4.77 −9.19 −0.35 −38% (95% CI −74 to −3)
Analysis 2.8 Anxiety (clinician) 2.8 Safren 2005 12.93 −5.68 −10.32 −1.04 −44% (95% CI −80 to −8)
Analysis 2.9 Anxiety (self‐reported) 2.9a Emilsson 2011 15.29 −4.29 −11.36 2.78 −28% (95% CI −74 to 18)
2.9b Safren 2005 7.2 −3.51 −6.53 −0.49 −49% (95% CI −91 to −7)
CBT versus other specific interventions
Analysis Name Control MD 95% CI % change
Analysis 3.1
ADHD symptoms (clinician)
3.1.1 Safren 2010 19.19 −4.73 −8.79 −0.67 −25 (95% CI −46 to −3)
3.1.2 Virta 2010 −4.50 −0.8 −1.6 0 18% (95% CI 0 to 36)
Analysis 3.2
ADHD symptoms (self‐reported)
3.2.1 Safren 2010 19.12 −7.28 −11.68 −2.88 −38% (95% CI −61 to −15)
3.2.2 Virta 2010 −10.55 −2.75 −14.93 9.43 26% (95% CI −89 to 142)
3.2.3 Vidal Estrada 2013 24.29 1.31 −5.92 8.54 5% (95% CI −24 to 35)
3.2.4 Fleming 2015 75.56 −15.27 −29.52 −1.02 −20% (95% CI −39 to −1)
Analysis 3.3
Inattention (self‐reported)
3.3.1 Vidal Estrada 2013 18.58 1.35 −4.62 7.32 7% (95% CI −25 to 39)
3.3.2 Fleming 2015 20.94 −2 −5.42 1.42 −10% (95% CI −26 to 7)
Analysis 3.4 Hyperactivity 3.4.1 Vidal Estrada 2013 13.88 1.72 −4.41 7.85 12% (95% CI −32 to 57)
Analysis 3.5 Impulsivity 3.5.1 Vidal Estrada 2013 14.76 2.84 −3.26 8.94 19% (95% CI −22 to 61)
Analysis 3.6
Clinical Global Impression (clinician)
3.6.1 Safren 2010 3.73 −0.53 −1.09 0.03 −14% (95% CI −29 to −1)
3.6.2 Vidal Estrada 2013 4.15 0.18 −0.19 0.55 4% (95% CI −5 to 13)
Analysis 3.7 Clinical Global
Impression (self‐reported)
3.7.1 Vidal Estrada 2013 4.17 0.29 −0.32 0.9 7% (95% CI −8 to 22)
Analysis 3.8
Depression (self‐reported)
3.8.1 Virta 2010 −1.67 −2.93 −8.88 3.02 175% (95% CI −181 to 532)
3.8.2 Vidal Estrada 2013 13.64 −1.24 −9.37 6.89 −9% (95% CI −69 to 51)
3.8.3 Fleming 2015 13.56 −2.91 −8.42 2.6 −21 (95% CI −62 to 19)
Analysis 3.9
Anxiety (self‐reported)
3.9.1 Vidal Estrada 2013 29.42 −4.22 −12.48 4.04 −14% (95% CI −42 to 14)
3.9.2 Fleming 2015 15.75 −5.93 −12.91 1.05 −38% (95% CI −82 to 7)
Analysis 3.10
Qualfeity of life (self‐reported)
3.10.1 Virta 2010 65.20 −4.3 −17.31 8.71 −7% (95% CI −27 to 13)
3.10.2 Vidal Estrada 2013 207.35 33.14 −35.76 102.04 16% (95% CI −17 to 49)
3.10.3 Fleming 2015 52.8 14.29 6.13 22.45 27% (95% CI 12 to 43)